1. Guidelines for the Prevention and Control of Carbapenem-Resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in Health Care Facilities,Geneva: World Health Organization; 2017.
2. Fupin HU, Yan GUO, Demei ZHU. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005–2014. Chin J Infect Chemother. 2017;17:93–9.
3. Chandy SJ, Naik GS, Balaji V, et al. High cost burden and health consequences of antibiotic resistance: the price to pay. J Infect Dev Ctries. 2014;8:1096–102.
4. Fupin HU, Yan GUO, Demei ZHU, et al. CHINET surveillance of bacterial resistance across China: report of the results in 2016. Chin J Infect Chemother. 2017;17:481–91.
5. Zhang Y, Wang Q, Yin Y, et al. Epidemiology of Carbapenem-resistant Enterobacteriaceae infections: report from the China CRE network. Antimicrob Agents Chemother. 2018;62:e01882–17.